In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback